Bone marrow cells with Wharton gel for liver cirrhosis
Part of Digestive system clinical trials.
This trial tests whether your own bone marrow cells, combined with a special gel from donated umbilical cords (Wharton's jelly exosomes), can help repair your liver. Researchers hope to improve liver function in people with cirrhosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have liver cirrhosis (scarred liver that doesn't work as well as it should).
- You must be under 80 years old.
- You cannot have any active cancer that is growing or spreading.
- You cannot have a severe infection that affects your whole body (severe sepsis).
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of stem cell therapy is safe for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. It may help if your liver disease is controlled and you have moderate to severe cirrhosis.
This trial tests a treatment made from stem cells to see if it is safe and can help reduce scarring and improve liver function in people with liver cirrhosis. It focuses on patients with moderate liver disease (Child-Pugh Class B).
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
This study tests whether stem cells from donated umbilical cords can help people with end-stage liver disease. Doctors want to see if the way the cells are given (like through a vein or artery) affects how well they work.
This trial tests whether giving a combination of two medicines (GCSF and Darbepoetin) one time or multiple times can help people with early-stage liver cirrhosis who have started to develop complications. The goal is to see if this treatment can improve liver function and delay the need for a transplant.
This trial tests if infusions of stem cells from donated umbilical cords can help people with a severe type of liver failure caused by hepatitis B. It aims to see if the treatment is safe and can improve liver function.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.